Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 1
2006 2
2007 4
2008 5
2009 5
2010 2
2011 4
2012 6
2013 11
2014 4
2015 7
2016 3
2017 7
2018 10
2019 14
2020 21
2021 24
2022 14
2023 21
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee JL, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Mai Y, Poehlein CH, Perini RF, Bajorin DF; KEYNOTE-045 Investigators. Bellmunt J, et al. N Engl J Med. 2017 Mar 16;376(11):1015-1026. doi: 10.1056/NEJMoa1613683. Epub 2017 Feb 17. N Engl J Med. 2017. PMID: 28212060 Free PMC article. Clinical Trial.
Heterogeneous circulating miRNA profiles of PBMAH.
Hara K, Murakami M, Niitsu Y, Takeuchi A, Horino M, Shiba K, Tsujimoto K, Komiya C, Ikeda K, Tsuiki M, Tanabe A, Tanaka T, Yokoyama M, Fujii Y, Naruse M, Yamada T. Hara K, et al. Among authors: yokoyama m. Front Endocrinol (Lausanne). 2022 Dec 13;13:1073328. doi: 10.3389/fendo.2022.1073328. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36583003 Free PMC article.
Hydronephrosis Caused by Metastatic Breast Cancer.
Sugimoto H, Oda G, Yokoyama M, Hayashi K, Yoshino M, Ogawa A, Hosoya T, Nakagawa T, Uetake H. Sugimoto H, et al. Among authors: yokoyama m. Case Rep Oncol. 2021 Mar 9;14(1):378-385. doi: 10.1159/000513903. eCollection 2021 Jan-Apr. Case Rep Oncol. 2021. PMID: 33776732 Free PMC article.
A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL).
Yoshida S, Takahara T, Arita Y, Ito M, Hayakawa S, Oguchi T, Komai Y, Numao N, Yuasa T, Inoue M, Ushijima H, Kudo S, Shimano Y, Nakamura Y, Uchida Y, Uehara S, Tanaka H, Yaegashi H, Izumi K, Yokoyama M, Matsuoka Y, Yoshioka Y, Konishi K, Nakanishi K, Nagahara A, Hirakawa A, Koike R, Koga F, Nishimura K, Mizokami A, Yonese J, Kageyama Y, Yoshimura R, Fujii Y. Yoshida S, et al. Among authors: yokoyama m. BMC Urol. 2023 Mar 6;23(1):33. doi: 10.1186/s12894-023-01202-z. BMC Urol. 2023. PMID: 36879257 Free PMC article. Clinical Trial.
Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review.
Kijima T, Fukushima H, Kusuhara S, Tanaka H, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Sakai Y, Saito K, Matsubara N, Yuasa T, Masuda H, Yonese J, Kageyama Y, Fujii Y. Kijima T, et al. Among authors: yokoyama m. Clin Genitourin Cancer. 2021 Jun;19(3):208-216.e1. doi: 10.1016/j.clgc.2020.07.003. Epub 2020 Jul 16. Clin Genitourin Cancer. 2021. PMID: 32800718 Review.
Undifferentiated prostate cancer treated with docetaxel.
Kobayashi M, Yokoyama M, Inoue M, Fujii Y. Kobayashi M, et al. Among authors: yokoyama m. IJU Case Rep. 2020 Apr 20;3(4):125-127. doi: 10.1002/iju5.12162. eCollection 2020 Jul. IJU Case Rep. 2020. PMID: 33392469 Free PMC article.
138 results